Exane Derivatives Dexcom Inc Transaction History

Exane Derivatives

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$67.99 - $132.89 $20,329 - $39,734	-299 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$94.08 - $130.2 $7,150 - $9,895	-76 Reduced 20.27%	299 $38,000
Q4 2021 Jan 28, 2022	SELL	$129.87 - $162.82 $14,415 - $18,073	-111 Reduced 22.84%	375 $50,000
Q3 2021 Oct 26, 2021	SELL	$106.71 - $143.18 $46,312 - $62,140	-434 Reduced 47.17%	486 $66,000
Q2 2021 Jul 28, 2021	BUY	$80.99 - $107.93 $14,578 - $19,427	180 Added 24.32%	920 $98,000
Q1 2021 Apr 30, 2021	SELL	$84.79 - $104.74 $27,048 - $33,412	-319 Reduced 30.12%	740 $66,000
Q4 2020 Jan 27, 2021	BUY	$78.0 - $104.5 $82,602 - $110,665	1,059 New	1,059 $97,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.